News | January 01, 2026
Rare arm cancer defeated: Indore doctors save patient’s arm with complex surgery
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
The accelerated review covers WCK 5222 for multiple critical infections
Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
The partnership also sets the stage for broader collaboration on rare disease treatments
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
The primary goal of the collaboration is joint research into trending and next-generation molecules
Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
